Organism name | Xanthoceras sorbifolia |
---|---|
Genus | Xanthoceras |
Family | Sapindaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Xanthoceras sorbifolium |
---|---|
Linked NCBI taxonomy ID | 99658 |
Linked level | species |
Family in NCBI taxonomy | Xanthoceraceae |
---|---|
ID | 910344 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00001071
![]() |
Myricetin
|
CHEMBL164
|
C040015
|
78 / 70 / 56 | 39 / 2 | No. 3 | No. 15 |
![]() |
C00040672
![]() |
Xanifolia Y8
|
CHEMBL1094358
|
2 / 0 / 0 | No. 4 | No. 51 |
![]() |
||
C00040671
![]() |
Xanifolia Y10
|
CHEMBL1094675
|
2 / 0 / 0 | No. 4 | No. 51 |
![]() |
||
C00019064
![]() |
Oleanolic acid
/ Astrantiagenin C / Virgaureagenin B / 3beta-Hydroxyolean-12-en-28-oic acid |
CHEMBL56615
CHEMBL168 CHEMBL180553 CHEMBL365375 CHEMBL486382 CHEMBL1413646 CHEMBL1436454 |
D009828
|
30 / 8 / 12 | 21 / 15 | No. 13 | No. 51 |
![]() |
C00000982
![]() |
Naringenin
/ (-)-Naringenin |
CHEMBL9352
CHEMBL32571 |
C005273
|
57 / 46 / 40 | 35 / 10 | No. 25 | No. 14 |
![]() |
C00000938
![]() |
Ampelopsin
/ Dihydromyricetin / (2R,3R)-3,5,7,3',4',5'-Hexahydroxyflavanone |
CHEMBL2048508
|
C106407
|
6 / 5 / 4 | 1 / 0 | No. 42 | No. 14 |
![]() |
C00000677
![]() |
Distylin
/ Dihydroquercetin / (2R,3R)-Taxifolin |
CHEMBL66
CHEMBL9249 CHEMBL337309 CHEMBL1492383 |
C003377
|
65 / 41 / 37 | 29 / 1 | No. 42 | No. 14 |
![]() |
C00000956
![]() |
(-)-Epicatechin
|
CHEMBL80941
CHEMBL311498 CHEMBL129482 CHEMBL200715 CHEMBL206452 CHEMBL583912 |
85 / 58 / 54 | No. 52 | No. 14 |
![]() |
||
C00008818
![]() |
Epigallocatechin
/ (-)-Epigallocatechin |
CHEMBL47386
CHEMBL125743 CHEMBL130415 CHEMBL264167 CHEMBL404845 |
26 / 17 / 29 | No. 52 | No. 14 |
![]() |
||
C00008805
![]() |
Epiafzelechin
|
CHEMBL159303
CHEMBL1326092 |
7 / 4 / 12 | No. 52 | No. 14 |
![]() |
||
C00046576
![]() |
24-Methylenecycloartan-3-ol
/ (+)-24-Methylenecycloartan-3-ol |
No. 129 | No. 11 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000956 C00000982 C00001071 C00008805 C00008818 C00019064 | 0 / 3 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000677 C00000956 C00000982 C00001071 C00008805 | 1 / 2 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000677 C00000956 C00001071 C00008805 C00008818 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000677 C00000956 C00000982 C00001071 C00008818 | 1 / 1 |
O00255 | Menin | Unclassified protein | C00000677 C00000956 C00000982 C00001071 C00008805 | 2 / 5 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000677 C00000956 C00000982 C00001071 C00008818 | 3 / 3 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000677 C00000956 C00001071 C00008818 C00019064 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00000677 C00000956 C00000982 C00001071 C00019064 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000677 C00000956 C00000982 C00001071 C00008805 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000677 C00000956 C00000982 C00001071 | 1 / 1 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000677 C00000956 C00000982 C00008818 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000677 C00000956 C00001071 C00008818 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000677 C00000956 C00000982 C00001071 | 0 / 1 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00000956 C00001071 C00040671 C00040672 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000956 C00008805 C00008818 C00019064 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000677 C00000956 C00000982 C00008818 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000677 C00000956 C00001071 C00008818 | 2 / 2 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000677 C00000956 C00001071 C00008818 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000677 C00000956 C00001071 C00008818 | 4 / 3 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000677 C00000956 C00000982 C00001071 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00000677 C00000956 C00001071 C00019064 | 0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000677 C00000956 C00000982 C00008818 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000677 C00000956 C00001071 C00008818 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00000677 C00001071 C00008818 C00019064 | 1 / 4 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00000677 C00001071 C00008818 C00019064 | 0 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000956 C00000982 C00001071 C00008818 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000956 C00000982 C00001071 C00008818 | 1 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000677 C00000956 C00000982 C00001071 | 1 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000677 C00000956 C00001071 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00000677 C00000956 C00001071 | 1 / 1 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000677 C00001071 C00019064 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00000982 C00001071 C00019064 | 2 / 2 |
P04745 | Alpha-amylase 1 | Enzyme | C00000956 C00000982 C00001071 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00000982 C00001071 C00019064 | 0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00000677 C00000956 C00001071 | 0 / 1 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00000677 C00000982 C00001071 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00000677 C00000982 C00019064 | 0 / 0 |
P56817 | Beta-secretase 1 | A1A | C00000677 C00000956 C00008818 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00000677 C00000956 C00001071 | 0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00000677 C00000982 C00001071 | 1 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000956 C00001071 C00008818 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000956 C00000982 C00019064 | 0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00000677 C00000982 C00001071 | 1 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000677 C00000956 C00001071 | 5 / 2 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000956 C00001071 C00008818 | 2 / 3 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000677 C00000956 C00001071 | 0 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00001071 C00040671 C00040672 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00000677 C00000956 C00001071 | 1 / 2 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000677 C00000956 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000677 C00000956 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00000677 C00000956 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000677 C00000956 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00000677 C00000956 | 1 / 1 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00000677 C00000956 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000982 C00001071 | 1 / 0 |
P00374 | Dihydrofolate reductase | Oxidoreductase | C00000956 C00008818 | 1 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | C00000677 C00000956 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000677 C00001071 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00000982 C00001071 | 0 / 0 |
P05771 | Protein kinase C beta type | Alpha | C00000677 C00000956 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00000677 C00000956 | 1 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000956 C00000982 | 5 / 1 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00000677 C00000956 | 4 / 1 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00000956 C00001071 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00000956 C00008818 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00000677 C00000956 | 0 / 1 |
Q05513 | Protein kinase C zeta type | Iota | C00000677 C00000956 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000956 C00000982 | 3 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00000982 C00001071 | 0 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00000982 C00001071 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00000677 C00001071 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00001071 C00019064 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00000677 C00000938 | 1 / 0 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00000956 C00001071 | 0 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00000677 C00001071 | 2 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00000956 C00008818 | 2 / 3 |
P10415 | Apoptosis regulator Bcl-2 | Other cytosolic protein | C00000956 C00008818 | 0 / 7 |
P04062 | Glucosylceramidase | Enzyme | C00000982 C00001071 | 6 / 4 |
P41743 | Protein kinase C iota type | Iota | C00000677 C00000956 | 0 / 0 |
P45452 | Collagenase 3 | M10A | C00000677 C00000938 | 1 / 1 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000677 C00000956 | 1 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00000677 C00001071 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00000982 C00001071 | 4 / 4 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000677 C00000938 | 2 / 2 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00000677 C00000956 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000677 C00000938 | 0 / 1 |
P39900 | Macrophage metalloelastase | M10A | C00000677 C00000938 | 0 / 0 |
P52209 | 6-phosphogluconate dehydrogenase, decarboxylating | Enzyme | C00000956 C00008818 | 0 / 0 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00000956 C00001071 | 0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00000956 C00001071 | 3 / 1 |
P08253 | 72 kDa type IV collagenase | M10A | C00000677 C00000938 | 1 / 3 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001071 | 0 / 0 |
Q9UM73 | ALK tyrosine kinase receptor | TKL serine/threonine protein kinase STKR type 1 subfamily | C00008805 | 1 / 1 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00001071 | 0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00000982 | 1 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00000677 | 0 / 0 |
P07711 | Cathepsin L1 | C1A | C00000956 | 0 / 0 |
P00734 | Prothrombin | S1A | C00000956 | 4 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000982 | 0 / 1 |
P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | C00001071 | 5 / 4 |
Q14790 | Caspase-8 | C14 | C00001071 | 2 / 1 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00000982 | 5 / 3 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00019064 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00001071 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000956 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000982 | 0 / 1 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000982 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00019064 | 0 / 0 |
P18433 | Receptor-type tyrosine-protein phosphatase alpha | Receptor tyrosine-protein phosphatase | C00019064 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000956 | 2 / 0 |
P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00019064 | 0 / 0 |
P16152 | Carbonyl reductase [NADPH] 1 | Enzyme | C00000982 | 0 / 0 |
P07998 | Ribonuclease pancreatic | Enzyme | C00000956 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00019064 | 0 / 0 |
P04278 | Sex hormone-binding globulin | Secreted protein | C00000982 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000956 | 0 / 1 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000956 | 1 / 2 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000956 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00000982 | 2 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001071 | 0 / 0 |
Q15746 | Myosin light chain kinase, smooth muscle | Mlck | C00001071 | 1 / 1 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000956 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00019064 | 0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000982 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000982 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001071 | 1 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000982 | 1 / 1 |
Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | C00001071 | 0 / 0 |
O75828 | Carbonyl reductase [NADPH] 3 | Enzyme | C00000982 | 0 / 0 |
P24864 | G1/S-specific cyclin-E1 | Other cytosolic protein | C00000982 | 0 / 2 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00001071 | 0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00000982 | 0 / 0 |
P35228 | Nitric oxide synthase, inducible | Enzyme | C00019064 | 1 / 1 |
P10586 | Receptor-type tyrosine-protein phosphatase F | Receptor tyrosine-protein phosphatase | C00019064 | 0 / 0 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00000982 | 0 / 0 |
P49327 | Fatty acid synthase | Transferase | C00000956 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00000982 | 1 / 0 |
Q15046 | Lysine--tRNA ligase | Enzyme | C00001071 | 2 / 1 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00000956 | 1 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001071 | 0 / 0 |
P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00019064 | 0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00001071 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000956 | 1 / 2 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001071 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000982 | 3 / 4 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00000982 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000956 | 0 / 0 |
P17706 | Tyrosine-protein phosphatase non-receptor type 2 | Tyr | C00019064 | 0 / 1 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000956 | 3 / 2 |
P62158 | Calmodulin | Unclassified protein | C00000982 | 1 / 0 |
P29350 | Tyrosine-protein phosphatase non-receptor type 6 | Tyr | C00019064 | 0 / 0 |
P04054 | Phospholipase A2 | Enzyme | C00019064 | 0 / 0 |
P49888 | Estrogen sulfotransferase | Enzyme | C00000982 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000956 | 1 / 1 |
Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00019064 | 0 / 0 |
P23469 | Receptor-type tyrosine-protein phosphatase epsilon | Receptor tyrosine-protein phosphatase | C00019064 | 0 / 0 |
P24666 | Low molecular weight phosphotyrosine protein phosphatase | Tyr | C00019064 | 0 / 0 |
P24298 | Alanine aminotransferase 1 | Enzyme | C00000677 | 0 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00000956 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000982 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00001071 | 1 / 1 |
Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | Tyr | C00019064 | 4 / 2 |
P42336 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Enzyme | C00001071 | 9 / 1 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000956 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000956 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000956 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000956 | 3 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000677 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000677 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00019064 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00001071 | 1 / 1 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000982 | 0 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000982 | 0 / 0 |
P31941 | DNA dC->dU-editing enzyme APOBEC-3A | Enzyme | C00001071 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00000982 | 1 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00000982 | 0 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001071 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001071 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00000956 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001071 | 2 / 1 |
Q9HCT0 | Fibroblast growth factor 22 | Unclassified protein | C00001071 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00000677
C00000982
C00001071
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000982
C00001071
C00019064
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000982
C00001071
C00019064
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000677
C00001071
C00019064
|
847 | CAT | catalase (EC:1.11.1.6) |
C00001071
C00019064
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00000982
C00001071
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000982
C00019064
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00000982
C00001071
|
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00001071
C00019064
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000982
C00001071
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000982
C00001071
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00001071
C00019064
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000982
C00001071
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000677
C00001071
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000677
C00019064
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000982
C00019064
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001071
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000677
|
4547 | MTTP, ABL, MTP | microsomal triglyceride transfer protein |
C00000677
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00000677
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000677
|
5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00000677
|
5921 | RASA1, CM-AVM, CMAVM, GAP, PKWS, RASA, RASGAP, p120GAP, p120RASGAP | RAS p21 protein activator (GTPase activating protein) 1 |
C00000677
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00000677
|
7187 | TRAF3, CAP-1, CAP1, CD40bp, CRAF1, IIAE5, LAP1 | TNF receptor-associated factor 3 |
C00000677
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000677
|
7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00000677
|
7507 | XPA, XP1, XPAC | xeroderma pigmentosum, complementation group A |
C00000677
|
7518 | XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 |
C00000677
|
10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00000982
|
10057 | ABCC5, ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP, pABC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
C00000982
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000982
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000982
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000982
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000982
|
249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00000982
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00000982
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00000677
|
9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00000677
|
2621 | GAS6, AXLLG, AXSF | growth arrest-specific 6 |
C00000677
|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000982
|
2248 | FGF3, HBGF-3, INT2 | fibroblast growth factor 3 |
C00000677
|
8817 | FGF18, FGF-18, ZFGF5 | fibroblast growth factor 18 |
C00000677
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00000677
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000982
|
1630 | DCC, CRC18, CRCR1, IGDCC1, MRMV1 | deleted in colorectal carcinoma |
C00000677
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000982
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000982
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000982
|
3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
C00000982
|
5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00000982
|
6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00000982
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00000677
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000982
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00000982
|
993 | CDC25A, CDC25A2 | cell division cycle 25A (EC:3.1.3.48) |
C00000677
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000982
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000982
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000982
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000982
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000982
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000982
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00000982
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00001071
|
397 | ARHGDIB, D4, GDIA2, GDID4, LYGDI, Ly-GDI, RAP1GN1, RhoGDI2 | Rho GDP dissociation inhibitor (GDI) beta |
C00001071
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001071
|
8900 | CCNA1 | cyclin A1 |
C00000677
|
891 | CCNB1, CCNB | cyclin B1 |
C00001071
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00001071
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00001071
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00001071
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00001071
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00001071
|
1786 | DNMT1, ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT | DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) |
C00001071
|
54583 | EGLN1, C1orf12, ECYT3, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2, SM20, ZMYND6 | egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) |
C00001071
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00001071
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00001071
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00001071
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000677
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00000677
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00001071
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00001071
|
8505 | PARG, PARG99 | poly (ADP-ribose) glycohydrolase (EC:3.2.1.143) |
C00001071
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001071
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00001071
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001071
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001071
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00001071
|
335 | APOA1 | apolipoprotein A-I |
C00000677
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00001071
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00001071
|
7161 | TP73, P73 | tumor protein p73 |
C00001071
|
8877 | SPHK1, SPHK | sphingosine kinase 1 (EC:2.7.1.91) |
C00000938
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00019064
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00019064
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00019064
|
3065 | HDAC1, GON-10, HD1, RPD3, RPD3L1 | histone deacetylase 1 (EC:3.5.1.98) |
C00019064
|
3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00019064
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00019064
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00019064
|
5052 | PRDX1, MSP23, NKEF-A, NKEFA, PAG, PAGA, PAGB, PRX1, PRXI, TDPX2 | peroxiredoxin 1 (EC:1.11.1.15) |
C00019064
|
5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00019064
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00019064
|
7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00019064
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00019064
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613780 | Aortic aneurysm, familial thoracic 7; aat7 |
Q15746
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#600807 | Asthma, susceptibility to |
Q13093
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#210900 | Bloom syndrome; blm |
P54132
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P42336
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#607271 | Caspase 8 deficiency |
Q14790
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
#114500 | Colorectal cancer; crc |
P18054
P42336 P84022 Q14191 |
#612918 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi |
P42336
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#615108 | Cowden syndrome 5; cws5 |
P42336
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
#610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#246200 | Donohue syndrome |
P06213
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#133239 | Esophageal cancer |
P18054
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#114550 | Hepatocellular carcinoma |
P08581
P42336 |
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
Q06124
|
#182000 | Keratosis, seborrheic |
P42336
|
#151100 | Leopard syndrome 1 |
Q06124
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
Q14790
|
#611162 | Malaria, susceptibility to |
P35228
|
#602501 | Megalencephaly-capillary malformation-polymicrogyria syndrome; mcap |
P42336
|
#603387 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; mpph |
P42336
|
#613839 | Megaloblastic anemia due to dihydrofolate reductase deficiency |
P00374
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#156250 | Metachondromatosis; metcds |
Q06124
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#613014 | Neuroblastoma, susceptibility to, 3; nblst3 |
Q9UM73
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#163950 | Noonan syndrome 1; ns1 |
Q06124
|
#601665 | Obesity |
P37231
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P42336
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#601367 | Stroke, ischemic |
P00734
P24723 |
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#614916 | Ventricular tachycardia, catecholaminergic polymorphic, 4; cpvt4 |
P62158
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P08581 (related) Q16790 (marker) |
H01197 | Dihydrofolate reductase (DHFR) deficiency |
P00374
(related)
|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
Q92731 (marker) |
H00028 | Choriocarcinoma |
P03956
(related)
P08253 (related) P10415 (related) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q99700 (related) Q9NUW8 (related) |
H00213 | Hypophosphatasia |
P05186
(related)
|
H00719 | Leprechaunism |
P06213
(related)
|
H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
H00025 | Penile cancer |
P08253
(related)
P14780 (related) P35354 (related) |
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00018 | Gastric cancer |
P08581
(related)
P10415 (related) P24864 (related) |
H00046 | Cholangiocarcinoma |
P08581
(related)
P35354 (related) |
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P10415
(related)
P28907 (marker) |
H00013 | Small cell lung cancer |
P10415
(related)
|
H00030 | Cervical cancer |
P10415
(related)
|
H00041 | Kaposi's sarcoma |
P10415
(related)
|
H00054 | Nasopharyngeal cancer |
P10415
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00408 | Type I diabetes mellitus |
P17706
(related)
Q04759 (related) |
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H00055 | Laryngeal cancer |
P24864
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00017 | Esophageal cancer |
P35228
(related)
P35354 (related) |
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00027 | Ovarian cancer |
P42336
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
Q01453
(related)
Q15046 (related) |
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00523 | Noonan syndrome and related disorders |
Q06124
(related)
|
H01018 | Metachondromatosis |
Q06124
(related)
|
H00108 | Autoimmune lymphoproliferative syndromes (ALPS) |
Q14790
(related)
|
H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) |
Q15746
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00014 | Non-small cell lung cancer |
Q9UM73
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D056486 | Drug-Induced Liver Injury |
C00000982
C00019064 |
D009369 | Neoplasms |
C00000982
C00019064 |
D008107 | Liver Diseases |
C00000982
C00019064 |
D008106 | Liver Cirrhosis, Experimental |
C00000982
C00019064 |
D007674 | Kidney Diseases |
C00000982
C00019064 |
D005909 | Glioblastoma |
C00001071
|
D006461 | Hemolysis |
C00000677
|
D009202 | Cardiomyopathies |
C00000982
|
D001932 | Brain Neoplasms |
C00000982
|
D000647 | Amnesia |
C00000982
|
D009374 | Neoplasms, Experimental |
C00000982
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00000982
|
D009203 | Myocardial Infarction |
C00001071
|
D002252 | Carbon Tetrachloride Poisoning |
C00019064
|
D050171 | Dyslipidemias |
C00019064
|
D018149 | Glucose Intolerance |
C00019064
|
D006949 | Hyperlipidemias |
C00019064
|
D007249 | Inflammation |
C00019064
|
D008103 | Liver Cirrhosis |
C00019064
|
D017202 | Myocardial Ischemia |
C00019064
|
D009765 | Obesity |
C00019064
|
D011041 | Poisoning |
C00019064
|
D011230 | Precancerous Conditions |
C00019064
|